153 related articles for article (PubMed ID: 8222167)
1. Captopril reduces graft coronary artery disease in a rat heterotopic transplant model.
Kobayashi J; Crawford SE; Backer CL; Zales VR; Takami H; Hsueh C; Huang L; Mavroudis C
Circulation; 1993 Nov; 88(5 Pt 2):II286-90. PubMed ID: 8222167
[TBL] [Abstract][Full Text] [Related]
2. Diltiazem preserves direct vasodilator response but fails to suppress intimal proliferation in rat allograft coronary artery disease.
Takami H; Backer CL; Crawford SE; Pahl E; Mavroudis C
J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):67-77. PubMed ID: 8820085
[TBL] [Abstract][Full Text] [Related]
3. A reduction in accelerated graft coronary disease and an improvement in cardiac allograft survival using low molecular weight heparin in combination with cyclosporine.
Aziz S; Tada Y; Gordon D; McDonald TO; Fareed J; Verrier ED
J Heart Lung Transplant; 1993; 12(4):634-43. PubMed ID: 8396435
[TBL] [Abstract][Full Text] [Related]
4. Amlodipine reduces graft coronary artery disease in rat heterotopic cardiac allografts.
Atkinson JB; Wudel JH; Hoff SJ; Stewart JR; Frist WH
J Heart Lung Transplant; 1993; 12(6 Pt 1):1036-43. PubMed ID: 8312305
[TBL] [Abstract][Full Text] [Related]
5. Electroporation-mediated interleukin-10 overexpression in skeletal muscle reduces acute rejection in rat cardiac allografts.
Tavakoli R; Gazdhar A; Pierog J; Bogdanova A; Gugger M; Pringle IA; Gill DR; Hyde SC; Genoni M; Schmid RA
J Gene Med; 2006 Feb; 8(2):242-8. PubMed ID: 16389627
[TBL] [Abstract][Full Text] [Related]
6. Captopril and platelet-activating factor (PAF) antagonist prevent cardiac allograft vasculopathy in rats: role of endogenous PAF and PAF-like compounds.
Crawford SE; Huang L; Hsueh W; Takami H; Gonzalez-Crussi F; Backer CL; Mu Y; Liu H; Mavroudis C
J Heart Lung Transplant; 1999 May; 18(5):470-7. PubMed ID: 10363692
[TBL] [Abstract][Full Text] [Related]
7. Two good reasons for an angiotensin-II type 1 receptor blockade with losartan after cardiac transplantation: reduction of incidence and severity of transplant vasculopathy.
Richter MH; Richter HR; Olbrich HG; Mohr FW
Transpl Int; 2003 Jan; 16(1):26-32. PubMed ID: 12545338
[TBL] [Abstract][Full Text] [Related]
8. Prolonged cold ischemic times and less donor-recipient histocompatibility accelerate graft vascular disease.
Czer LS; Wong AV; Soukiasian H; Gallagher S; De Robertis M; Trento A
Transplant Proc; 2011 Dec; 43(10):3863-8. PubMed ID: 22172861
[TBL] [Abstract][Full Text] [Related]
9. Effect of dose of cyclosporine or FK506 and antithrombotic agents on cardiac allograft vascular disease in heterotopically transplanted hearts in rats.
Hisatomi K; Isomura T; Ohashi M; Tamehiro K; Sato T; Tayama E; Ohishi K; Kohjiro M
J Heart Lung Transplant; 1995; 14(1 Pt 1):113-8. PubMed ID: 7537098
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of heart transplant injury and graft coronary artery disease after prolonged organ ischemia by selective protein kinase C regulators.
Tanaka M; Gunawan F; Terry RD; Inagaki K; Caffarelli AD; Hoyt G; Tsao PS; Mochly-Rosen D; Robbins RC
J Thorac Cardiovasc Surg; 2005 May; 129(5):1160-7. PubMed ID: 15867794
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II receptor antagonist TCV-116 reduces graft coronary artery disease and preserves graft status in a murine model. A comparative study with captopril.
Furukawa Y; Matsumori A; Hirozane T; Sasayama S
Circulation; 1996 Jan; 93(2):333-9. PubMed ID: 8548907
[TBL] [Abstract][Full Text] [Related]
12. A new rat infection-heart transplant model: effect of infection on graft survival studies.
Kobayashi J; Mavroudis C; Crawford SE; Zales VR; Backer CL
J Heart Lung Transplant; 1993; 12(4):659-64. PubMed ID: 7690253
[TBL] [Abstract][Full Text] [Related]
13. Effects of fish oil on graft arteriosclerosis and MHC class II antigen expression in rat heterotopic cardiac allografts.
Yun KL; Michie SA; Fann JI; Billingham ME; Miller DC
J Heart Lung Transplant; 1991; 10(6):1004-11. PubMed ID: 1756147
[TBL] [Abstract][Full Text] [Related]
14. Influence of gender on allograft rejection in a rat heart transplant model.
Takami H; Backer CL; Crawford SE; Zales VR; Mavroudis C
J Heart Lung Transplant; 1995; 14(3):529-36. PubMed ID: 7654736
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of graft coronary arteriosclerosis after heart transplantation.
Soukiasian HJ; Czer LS; Wang HM; Luthringer D; Wang C; Kamlot A; Quartel A; Trento A
Am Surg; 2004 Oct; 70(10):833-40. PubMed ID: 15529833
[TBL] [Abstract][Full Text] [Related]
16. The impact of FK506 on graft coronary disease of rat cardiac allograft--a comparison with cyclosporine.
Arai S; Teramoto S; Senoo Y
J Heart Lung Transplant; 1992; 11(4 Pt 1):757-62. PubMed ID: 1379829
[TBL] [Abstract][Full Text] [Related]
17. Low molecular weight fucan prevents transplant coronaropathy in rat cardiac allograft model.
Alkhatib B; Freguin-Bouilland C; Lallemand F; Henry JP; Litzler PY; Marie JP; Richard V; Thuillez C; Plissonnier D
Transpl Immunol; 2006 Jun; 16(1):14-9. PubMed ID: 16701171
[TBL] [Abstract][Full Text] [Related]
18. Effect of single-dose rapamycin-based immunosuppression on the development of cardiac allograft vasculopathy.
Goggins WC; Fisher RA; Cohen DS; Tawes JW; Grimes MM
J Heart Lung Transplant; 1996 Aug; 15(8):790-5. PubMed ID: 8878761
[TBL] [Abstract][Full Text] [Related]
19. Different immune effects on cardiac allografts and xenografts induced by neonatal intrathymic inoculation with allogeneic and xenogeneic antigens.
Shen Z; Pelletier S; Mohiuddin M; Yokoyama H; Reiss GR; DiSesa VJ
J Heart Lung Transplant; 1996 Oct; 15(10):1034-8. PubMed ID: 8913921
[TBL] [Abstract][Full Text] [Related]
20. Low-dose cyclosporine treatment fails to prevent coronary luminal narrowing after heart transplantation.
Vassalli G; Kaski JC; Tousoulis D; Kiowski W; Turina M; Follath F; Gallino A
J Heart Lung Transplant; 1996 Jun; 15(6):612-9. PubMed ID: 8794036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
